Evergreen Capital Management LLC Acquires New Shares in CorVel Corp. $CRVL

Evergreen Capital Management LLC acquired a new position in shares of CorVel Corp. (NASDAQ:CRVL) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 11,584 shares of the business services provider’s stock, valued at approximately $784,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in CorVel by 0.7% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,961 shares of the business services provider’s stock valued at $1,640,000 after purchasing an additional 115 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of CorVel by 0.9% during the second quarter. The Manufacturers Life Insurance Company now owns 15,918 shares of the business services provider’s stock worth $1,636,000 after buying an additional 139 shares during the period. Arizona State Retirement System grew its holdings in CorVel by 1.7% in the 3rd quarter. Arizona State Retirement System now owns 9,113 shares of the business services provider’s stock worth $706,000 after buying an additional 155 shares in the last quarter. Hantz Financial Services Inc. increased its position in CorVel by 61.3% in the 3rd quarter. Hantz Financial Services Inc. now owns 500 shares of the business services provider’s stock valued at $39,000 after acquiring an additional 190 shares during the period. Finally, Wealth Enhancement Advisory Services LLC raised its stake in CorVel by 1.6% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 13,697 shares of the business services provider’s stock valued at $962,000 after acquiring an additional 210 shares in the last quarter. Institutional investors and hedge funds own 51.36% of the company’s stock.

CorVel Stock Up 1.0%

NASDAQ:CRVL opened at $57.33 on Friday. The business’s 50-day moving average price is $53.30 and its 200 day moving average price is $63.70. CorVel Corp. has a 52-week low of $44.83 and a 52-week high of $117.22. The firm has a market cap of $2.93 billion, a P/E ratio of 28.10 and a beta of 1.05.

CorVel (NASDAQ:CRVL) last posted its quarterly earnings data on Tuesday, February 3rd. The business services provider reported $0.47 earnings per share for the quarter. The company had revenue of $235.63 million during the quarter. CorVel had a net margin of 11.23% and a return on equity of 30.15%.

Insiders Place Their Bets

In other CorVel news, insider Maxim Shishin sold 2,400 shares of the company’s stock in a transaction on Monday, March 16th. The stock was sold at an average price of $54.00, for a total value of $129,600.00. Following the transaction, the insider owned 7,050 shares of the company’s stock, valued at approximately $380,700. This represents a 25.40% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 44.56% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered CorVel from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, April 6th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, CorVel currently has an average rating of “Sell”.

About CorVel

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).